Reifen Ram, Nissenkorn Andreea, Matas Zippora, Bujanover Yoram
The School of Nutritional Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
J Gastroenterol. 2004 Jun;39(6):514-9. doi: 10.1007/s00535-003-1336-z.
Supplementation of 5-aminosalicylic acid (5-ASA) and of iron are among the principal therapies in patients with inflammatory bowel disease. Therapeutic iron, as well as heme iron from chronic mucosal bleeding, can increase iron-mediated oxidative stress in colitis. This study was designed to examine the influence of iron supplementation on histological expression and oxidative status relative to 5-ASA treatment and antioxidant treatment.
Colitis was induced using the iodoacetamide rat model, and rats were divided into different dietary groups of 6 rats each: 1, normal chow diet (control); 2, diet supplemented with iron; 3, iron supplementation and lycopene; 4, iron and Beta-carotene; 5, 5-ASA; 6, 5-ASA and lycopene; 7, 5-ASA and iron; 8, 5-ASA, iron, and lycopene. The animals were killed after 3 days and the weight of the ulcerated area recorded. Mucosal specimens were histologically evaluated. Myeloperoxidase (MPO) was measured to evaluate inflammatory status (U/g). Malondialdehyde (MDA) was measured in colonic tissue ( micro mol/g) and superoxide dismutase (SOD) in erythrocytes to assess the degree of tissue oxidative stress.
Significantly more severe colitis, including necrosis, ulceration, and hemorrhage, was seen in colonic biopsies of rats with colitis when iron was supplemented. This pathology was attenuated when iron was given in combination with 5-ASA and/or lycopene. There was no significant benefit from adding Beta-carotene.
Iron supplementation can amplify the inflammatory response and subsequent mucosal damage in a rat model of colitis. We suggest that the resultant oxidative stress generated by iron supplementation leads to the extension and propagation of crypt abscesses, either through direct membrane disruption by lipid peroxidation or through the generation of secondary toxic oxidants. Simultaneous treatment with 5-ASA and/or lycopene minimizes the potential hazard of iron. Therefore, we suggest giving iron supplementation with 5-ASA or lycopene or both.
补充5-氨基水杨酸(5-ASA)和铁是炎症性肠病患者的主要治疗方法。治疗性铁以及慢性黏膜出血产生的血红素铁可增加结肠炎中铁介导的氧化应激。本研究旨在探讨相对于5-ASA治疗和抗氧化治疗,补充铁对组织学表达和氧化状态的影响。
使用碘乙酰胺大鼠模型诱导结肠炎,将大鼠分为不同饮食组,每组6只:1. 正常饲料饮食(对照组);2. 补充铁的饮食;3. 补充铁和番茄红素;4. 铁和β-胡萝卜素;5. 5-ASA;6. 5-ASA和番茄红素;7. 5-ASA和铁;8. 5-ASA、铁和番茄红素。3天后处死动物,记录溃疡面积的重量。对黏膜标本进行组织学评估。测量髓过氧化物酶(MPO)以评估炎症状态(U/g)。测量结肠组织中的丙二醛(MDA)(微摩尔/克)和红细胞中的超氧化物歧化酶(SOD)以评估组织氧化应激程度。
补充铁的结肠炎大鼠结肠活检中可见更严重的结肠炎,包括坏死、溃疡和出血。当铁与5-ASA和/或番茄红素联合使用时,这种病理情况会减轻。添加β-胡萝卜素没有显著益处。
在大鼠结肠炎模型中,补充铁可放大炎症反应及随后的黏膜损伤。我们认为,补充铁产生的氧化应激通过脂质过氧化直接破坏细胞膜或通过产生继发性毒性氧化剂导致隐窝脓肿的扩展和蔓延。同时用5-ASA和/或番茄红素治疗可将铁的潜在危害降至最低。因此,我们建议补充铁时同时给予5-ASA或番茄红素或两者都用。